Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2019-03-22, Stock:LLY, The news for the past five days is as follows:
2019-03-15: NEWS1: Pharma Stock Roundup: Regulatory Updates From MRK, PFE, J&J, AGN & Others.NEWS2: Pharma Stock Roundup: Regulatory Updates From MRK, PFE, J&J, AGN & Others.NEWS3: The Case Against Pfizer Stock and the Rest of the Industry.NEWS4: The Case Against Pfizer Stock and the Rest of the Industry.NEWS5: Pharma Stock Roundup: Regulatory Updates From MRK, PFE, J&J, AGN & Others.NEWS6: The Case Against Pfizer Stock and the Rest of the Industry.
2019-03-18: NEWS1: After Hours Most Active for Mar 18, 2019 :  ELAN, LLY, BAC, MRK, HPQ, WMB, QCOM, GILD, CMCSA, PEP, EBAY, ATVI.NEWS2: After Hours Most Active for Mar 18, 2019 :  ELAN, LLY, BAC, MRK, HPQ, WMB, QCOM, GILD, CMCSA, PEP, EBAY, ATVI.
2019-03-19: NEWS1: After Hours Most Active for Mar 19, 2019 :  TFCFA, TFCF, LLY, BRX, TWTR, BAC, PFE, EBAY, S, MSFT, CMCSA, INTC.NEWS2: After Hours Most Active for Mar 19, 2019 :  TFCFA, TFCF, LLY, BRX, TWTR, BAC, PFE, EBAY, S, MSFT, CMCSA, INTC.NEWS3: Why Analysts Still Favor Eli Lilly and Company Stock.NEWS4: See what the IHS Markit Score report has to say about Eli Lilly and Co..
2019-03-20: NEWS1: Eli Lilly Stock Is Up Because UBS Sees Reasons to Be Bullish.NEWS2: NCCN Announces Six Quality Improvement Projects in Gastric Cancer Care Approved for Collaboration with Lilly Oncology.
2019-03-21: NEWS1: Biogen’s Big Bet in Alzheimer’s Disease Is a Bust.NEWS2: Biogen’s Big Bet in Alzheimer’s Disease Is a Bust.NEWS3: Alkermes Focuses on Pipeline, Depends on Partners for Funds.NEWS4: Alkermes Focuses on Pipeline, Depends on Partners for Funds.NEWS5: Alkermes Focuses on Pipeline, Depends on Partners for Funds.NEWS6: Biogen shares tank nearly 30% after pulling key Alzheimer’s drug trial.NEWS7: 9 High-Margin Stocks Seen Leading in Fed's New Dovish Era.

Answer: Decrease